1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione

Catalog No. :
ACNPJB720
CAS No. :
3056-17-5
Molecular Formula :
C10H12N2O4
Molecular Weight :
224.08

IUPAC Name:1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione

1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g95%$75.00Login to see priceIn stockInquiry
100g95%$204.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
IUPAC Name1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
MDL No.MFCD00132921
Molecular FormulaC10H12N2O4
Molecular Weight224.08
SMILESO=C1N(C=C(C(N1)=O)C)[C@@H]2O[C@@H](C=C2)CO
InChI KeyXNKLLVCARDGLGL-JGVFFNPUSA-N
SynonymBO9LE4QFZF | Zerit(TM) | 3'-Deoxy-2'-thymidinene | ddeTyd | HMS3259L21 | HMS3428C07 | 1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione | 2',3'-Didehydro-3'-deoxythymidine | 3'-deoxythymidin-2'-ene | HMS3039O05 | Stav
CAS No.3056-17-5
PubChem CID18283

Safety Data

Pictogram
Health hazard
Signal Word
Warning
Hazard Statement(s)
H341-H373
Precautionary Statement(s)
P201-P202-P260-P280-P308+P313-P501

Synthetic Route by SureRoute

1. ACNPJB720 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNPJB720 route product structure diagram
    ACNPJB7203056-17-5 In Stock
Inquiry

2. ACNPJB720 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNPJB720 route product structure diagram
    ACNPJB7203056-17-5 In Stock
Inquiry

Comments (0)